US Patent 11833119 Combination therapies for the treatment of hepatocellular carcinoma

Overview Structured Data Issues Contributors Activity

All edits

Edits on 7 Dec, 2023

"Created via: Patent importer"

Golden AI

created this topic on 7 Dec, 2023

Edits made to:

Infobox (+14 properties)

Article (+167 characters)

‌

US Patent 11833119 Combination therapies for the treatment of hepatocellular carcinoma

Article

Patent abstract

Provided herein is a combination therapy useful for the treatment hepatocellular carcinoma. The combination comprises an FGFR4 inhibitor and lenvatinib.

Infobox

Is a

Patent

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118331190

Patent Inventor Names

Anand Selvaraj0

Peter Smith0

Date of Patent

December 5, 2023

Patent Application Number

169612920

Date Filed

January 9, 2019

Patent Citations

‌

US Patent 7253286 Nitrogen-containing aromatic derivatives

‌

US Patent 7612208 Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same

‌

US Patent 9006256 Antitumor agent for thyroid cancer

‌

US Patent 9434697 Pyrimidine FGFR4 inhibitors

‌

US Patent 10736900 Combinations of an FGFR inhibitor and an IGF1R inhibitor

Patent Primary Examiner

‌

Celeste A Roney

Find more entities like US Patent 11833119 Combination therapies for the treatment of hepatocellular carcinoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API